Medical device company DexCom (NASDAQ:DXCM) reported Q2 CY2026 results beating Wall Street’s revenue expectations, with sales ...

In late July 2026, DexCom reported second-quarter results showing higher sales and earnings than a year earlier and raised its full-year 2026 revenue outlook to US$5.18 billion–US$5.25 billion, ...

DXCM's Q2 earnings and revenues beat estimates as global demand, broader access and margin expansion fuel stronger 2026 ...

MUMBAI: A pet dog with uncontrolled blood sugar levels just got a tech device to keep track of his glucose levels. The 3-year-old male pug has been wearing the ‘continuous glucose monitor', or CGM, ...

We have the data. Now how can we inflluence decisions? Wearables can impact our health- but doctors need to be on board.